Teva Contemplating Sale Of Women's Health Unit For Debt Relief
Teva Pharmaceutical (TEVA) is contemplating the sale of its women's health unit as it seeks debt relief, Bloomberg reports.
Teva's women's health business could sell for $2 billion, according to the report.
Teva's women's health business could sell for $2 billion, according to the report.